VITROLIFE´S INTERIM REPORT, JANUARY - MARS 2002
* Net sales increased by 69% and amounted to 32,8 MSEK (19,4 MSEK).
* Gross profit increased by 158 % and amounted to 16,5 MSEK (6,4
* Operating result was improved and amounted to -4,0 MSEK (-13,3
* CE-mark approval was received for new coronary by pass surgery kit
developed by business area Transplantation Systems.
* CE-mark approval was received for a new product for use in
ophthalmic surgery developed by business area Biosupportive Systems.
See attached interim report in Swedish with financial data in English
Göteborg 23 April 2002
Vitrolife AB (publ)
For information, please contact:
Vitrolife: President and CEO Dr. Peter Svalander, tel +46-31-721 80 01
CFO Stefan Jacobsson, tel +46-31-721 80 10
Vitrolife's business mission is to develop, produce and sell advanced
products and systems for the preparation, cultivation, preservation and
support of cells, tissues and organs. Vitrolife intends to further
expand the Company's production capacity to meet an expected increase in
demand for its products, as well as strengthen its global market
position as a leading company in the development of innovative cell and
Vitrolife believes that the number of procedures performed annually
involving tissue and cell technologies will increase as new treatments
are introduced and existing treatments are improved. In addition,
Vitrolife expects that the regulation surrounding approval processes and
quality control for its products will increase. Vitrolife aims to create
competitive advantages from this regulation by meeting and exceeding
expected future demands of regulatory authorities, ahead of the
Since it commenced its operations in 1993, Vitrolife has expanded
rapidly. The Company currently has over 100 employees and sells its
products in over 80 countries. During the latest five-year period, sales
have steadily increased by and totalled more than SEK 100 million for
the fiscal year 2001.
The Vitrolife share is listed on the Stockholm Exchange
(Stockholmsbörsen) O-list under the ticker VITR.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2002/04/23/20020423BIT00170/wkr0002.pdf The full report